Vor Biopharma VOR Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $169.87M-57.2% | $396.49M+147% | $160.46M-15.8% | $190.57M+281% | $50.05M-38.9% | ||
| $321.65M+448% | $58.72M+487% | $10M+0.1% | $9.99M0.0% | $9.99M+0.1% | ||
| $6.39M+455% | $1.15M+54.2% | $747K-50.2% | $1.5M-66.8% | $4.52M+7.5% | ||
| $500.78M+9.3% | $458.11M+166% | $172.49M-15.8% | $204.93M+216% | $64.85M-32.8% | ||
| $565K+6.0% | $533K+96.7% | $271K— | $0-100% | $5.99M-9.0% | ||
| $2.83M-3.7% | $2.94M-3.5% | $3.04M+12,579% | $24K-99.9% | $33.7M-3.7% | ||
| $2.41M+1.0% | $2.38M+786% | $269K-36.0% | $420K-82.3% | $2.37M-0.6% | ||
| $506.75M+9.2% | $464.13M+163% | $176.24M-14.2% | $205.37M+87.9% | $109.31M-23.5% | ||
| $1.04M-79.7% | $5.13M+479% | $885K+32.3% | $669K-82.1% | $3.73M+148% | ||
| $14.73M-25.5% | $19.76M+11.6% | $17.7M-69.5% | $58.1M+131,955% | $44K-99.7% | ||
| $307K+9.6% | $280K+11.1% | $252K— | $0-100% | $4.27M+1.2% | ||
| $16.08M-36.1% | $25.17M+33.6% | $18.84M-67.9% | $58.77M+251% | $16.73M-10.1% | ||
| $2.63M-3.2% | $2.72M-3.1% | $2.81M— | $0-100% | $26.52M-4.0% | ||
| $2.94M-2.0% | $3M-1.9% | $3.06M— | $0-100% | $30.78M-3.3% | ||
| $657.17M+4.6% | $628.44M-73.8% | $2.4B+40.4% | $1.71B+3,857% | $43.24M-6.5% | ||
| $19K+5.6% | $18K+20.0% | $15K+15.4% | $13K0.0% | $13K0.0% | ||
| $1.22B+23.7% | $988.6M+52.0% | $650.32M+16.7% | $557.42M+0.3% | $555.51M+0.3% | ||
| -$1.37B-19.0% | -$1.15B+59.9% | -$2.88B-39.4% | -$2.06B-321% | -$489.48M-7.1% | ||
| -$706K-1,822% | $41K+242% | $12K-14.3% | $14K-39.1% | $23K+4.5% | ||
| -$150.42M+8.5% | -$164.31M+92.6% | -$2.23B-47.8% | -$1.51B-2,379% | $66.07M+168% | ||
| $506.75M+9.2% | $464.13M+163% | $176.24M-14.2% | $205.37M+87.9% | $109.31M-23.5% | ||
| $321.65M+448% | $58.72M+487% | $10M+0.1% | $9.99M0.0% | $9.99M+0.1% | ||
| $2.86M+63.8% | $1.75M+36.6% | $1.28M+184% | $449K+51.2% | $297K-21.8% | ||
| $2.41M+1.0% | $2.38M+786% | $269K-36.0% | $420K-82.3% | $2.37M-0.6% | ||
| $2.83M-3.7% | $2.94M-3.5% | $3.04M+12,579% | $24K-99.9% | $33.7M-3.7% | ||
| $2.83M-3.7% | $2.94M-3.5% | $3.04M+12,579% | $24K-99.9% | $33.7M-3.7% | ||
| $2.41M+1.0% | $2.38M+786% | $269K-36.0% | $420K-82.3% | $2.37M-0.6% | ||
| $2.83M-3.7% | $2.94M-3.5% | $3.04M+12,579% | $24K-99.9% | $33.7M-3.7% | ||
| $2.41M+1.0% | $2.38M+786% | $269K-36.0% | $420K-82.3% | $2.37M-0.6% | ||
| $14.73M-25.5% | $19.76M+11.6% | $17.7M-69.5% | $58.1M+569% | $8.69M-32.6% | ||
| $14.73M-25.5% | $19.76M+11.6% | $17.7M-69.5% | $58.1M+569% | $8.69M-32.6% | ||
| $2.94M-2.0% | $3M-1.9% | $3.06M— | —— | $30.78M-3.3% | ||
| $1.22B+23.7% | $988.6M+52.0% | $650.32M+16.7% | $557.42M+0.3% | $555.51M+0.3% | ||
| $19K+5.6% | $18K+20.0% | $15K+15.4% | $13K0.0% | $13K0.0% | ||
| $6.39M+455% | $1.15M+54.2% | $747K-50.2% | $1.5M-66.8% | $4.52M+7.5% | ||
| $168K0.0% | $168K0.0% | $168K— | $0-100% | $2.41M0.0% | ||
| $638.46M+6.3% | $600.55M-74.8% | $2.38B+44.0% | $1.65B— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vor Biopharma's total assets?
- Vor Biopharma (VOR) holds $506.7M in total assets, up 363.6% year over year.
- How much debt does Vor Biopharma have?
- Vor Biopharma carries $2.9M in total debt against -$150.4M of shareholders' equity, a debt-to-equity ratio of 0.47.
- How much cash does Vor Biopharma have?
- Vor Biopharma holds $169.9M in cash and equivalents.
- Can Vor Biopharma cover its short-term obligations?
- Its current ratio is 31.15 — current assets exceed current liabilities.
- Where does Vor Biopharma's balance sheet data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.